Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
SR One Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
SR One Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
SR One Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
SR One Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
SR One Ltd, Medical Devices Deals, 2011 to YTD 2017 12
SR One Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 13
SR One Ltd, Pharmaceuticals & Healthcare, Deal Details 23
Venture Financing 23
Palleon Pharma Raises USD47.6 Million in Series A Financing 23
eFFECTOR Therapeutics Raises USD38.6 Million in Series C Financing 24
Bicycle Therapeutics Raises USD51.35 Million in Series B Round of Financing 26
TP Therapeutics Raises USD45 Million in Series C Financing 28
Pulmocide Raises USD30.4 Million in Series B Financing 29
Spero Therapeutics Raises USD51.7 Million in Series C Financing 31
Tioma Therapeutics Raises USD86 Million in Series A Financing 33
Second Genome Raises USD8.4 Million in Extended Series B Financing 34
Morphic Therapeutic Raises USD51.5 Million in Series A Venture Financing 35
Spero Therapeutics to Raise USD30 Million in Series B Preferred Financing 36
Mission Therapeutics Raises USD85.7 Million in Financing Round 37
Effector Therapeutics Raises USD40 Million in Series B Venture Financing 39
Navitor Pharma Raises USD33 Million in Series B Financing 41
Constellation Pharma Raises USD55 Million Financing 43
True North Therapeutics Raises USD40 Million in Series C Financing 45
Decibel Therapeutics Raises USD52 Million in Series A Financing Round 47
Asceneuron Raises USD30.6 Million in Series A Financing 48
Gladius Pharma Raises USD3.3 Million in Series A Financing 50
Atopix Therapeutics Raises Additional Funds through Venture Financing 51
Spero Therapeutics Raises USD30 Million in Extended Series A Financing 52
PsiOxus Therapeutics Raises USD39.2 Million in Series C Financing 53
CRISPR Therapeutics Raises Additional USD35 Million in Series A Financing 55
CRISPR Therapeutics Raises USD29 Million in Series B Financing 57
ZappRx Raises USD5.6 Million in Series A Financing 59
Thrasos Therapeutics Raises USD21 Million in Series D Financing 60
Nimbus Therapeutics Raises USD43 Million in Series B Financing 62
Macrolide Pharma Raises USD22 Million in Series A Financing 63
Aileron Therapeutics Raises USD33 Million in Extended Series E Venture Financing 64
Bicycle Therapeutics Raises USD32 Million in Series A Venture Financing 66
Atopix Therapeutics Raises Funds through Extended Series A Financing 67
Atox Bio Raises up to USD23 Million in Series E Venture Financing 68
Navitor Pharma Raises USD24 Million in Series A Financing 69
True North Therapeutics Raises USD22 Million in Series A Venture Financing 71
Principia Biopharma Raises US$50 Million In Series B Venture Financing 73
Spero Therapeutics Raises USD3 Million in Series A Venture Financing 75
Alios BioPharma Raises US$41 Million In Series B Venture Financing 76
RuiYi Raises US$15 Million In Series B Financing 77
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 79
VHsquared Secures Series A Funding Round 80
Aileron Therapeutics Raises US$30 Million In Series E Financing 81
Mission Therapeutics Raises US$32 Million In Series B Financing 83
F-Star Alpha Raises US$13 Million In Series A Financing 84
iPierian Raises US$30 Million In Series A Venture Financing 85
Effector Therapeutics Raises US$45 Million In Series A Financing 87
Progenitor Labs Raises US$5.8 Million In Seed Financing 89
Aileron Raises US$12 Million In Extended Series D Financing 90
River Vision Development Raises US$17 Million In Series A Financing 92
Bicycle Therapeutics Raises US$6 Million In Venture Financing 93
Applied Genetic Technologies Raises US$37.5 Million In Series B Financing 95
HTG Molecular Diagnostics Raises US$7.5 Million In Series E Financing 97
Thrasos Therapeutics Raises US$35 Million In Venture Financing 98
SR One Plans To Invest In Biotechnology Company 100
Genocea Biosciences Raises US$30 Million In Series C Financing 101
Principia Biopharma Raises Additional US$13 Million In Series A Financing 103
PsiOxus Therapeutics Raises Additional US$34 Million In Series B Financing 105
RaNA Therapeutics Raises Additional US$18 Million In Series A Financing 107
Mission Therapeutics Raises US$10 Million In Series A Financing 109
Nimbus Discovery Secures US$24 Million In Series A Financing 110
High Throughput Genomics Secures US$0.5 Million In Second Closing Of Series D Venture Round 111
Constellation Pharma Secures Additional US$15 Million In Series B Financing 112
f-star Secures US$21.7 Million In Financing Round 114
Principia Biopharma Raises US$12 Million In First Tranche Of Series A Financing 116
Genocea Biosciences Secures US$35 Million In Series B Venture Financing 117
Acquisition 119
Ipsen Acquires Syntaxin, Life Sciences Company, For US$206 Million 119
SuperGen Completes Acquisition Of Astex Therapeutics 121
SR One Ltd – Key Competitors 124
SR One Ltd – Key Employees 125
SR One Ltd – Locations And Subsidiaries 126
Head Office 126
Other Locations & Subsidiaries 126
Appendix 127
Methodology 127
About GlobalData 127
Contact Us 127
Disclaimer 127
SR One Ltd, Pharmaceuticals & Healthcare, Key Facts 2
SR One Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
SR One Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
SR One Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
SR One Ltd, Deals By Therapy Area, 2011 to YTD 2017 10
SR One Ltd, Medical Devices Deals, 2011 to YTD 2017 12
SR One Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 13
Palleon Pharma Raises USD47.6 Million in Series A Financing 23
eFFECTOR Therapeutics Raises USD38.6 Million in Series C Financing 24
Bicycle Therapeutics Raises USD51.35 Million in Series B Round of Financing 26
TP Therapeutics Raises USD45 Million in Series C Financing 28
Pulmocide Raises USD30.4 Million in Series B Financing 29
Spero Therapeutics Raises USD51.7 Million in Series C Financing 31
Tioma Therapeutics Raises USD86 Million in Series A Financing 33
Second Genome Raises USD8.4 Million in Extended Series B Financing 34
Morphic Therapeutic Raises USD51.5 Million in Series A Venture Financing 35
Spero Therapeutics to Raise USD30 Million in Series B Preferred Financing 36
Mission Therapeutics Raises USD85.7 Million in Financing Round 37
Effector Therapeutics Raises USD40 Million in Series B Venture Financing 39
Navitor Pharma Raises USD33 Million in Series B Financing 41
Constellation Pharma Raises USD55 Million Financing 43
True North Therapeutics Raises USD40 Million in Series C Financing 45
Decibel Therapeutics Raises USD52 Million in Series A Financing Round 47
Asceneuron Raises USD30.6 Million in Series A Financing 48
Gladius Pharma Raises USD3.3 Million in Series A Financing 50
Atopix Therapeutics Raises Additional Funds through Venture Financing 51
Spero Therapeutics Raises USD30 Million in Extended Series A Financing 52
PsiOxus Therapeutics Raises USD39.2 Million in Series C Financing 53
CRISPR Therapeutics Raises Additional USD35 Million in Series A Financing 55
CRISPR Therapeutics Raises USD29 Million in Series B Financing 57
ZappRx Raises USD5.6 Million in Series A Financing 59
Thrasos Therapeutics Raises USD21 Million in Series D Financing 60
Nimbus Therapeutics Raises USD43 Million in Series B Financing 62
Macrolide Pharma Raises USD22 Million in Series A Financing 63
Aileron Therapeutics Raises USD33 Million in Extended Series E Venture Financing 64
Bicycle Therapeutics Raises USD32 Million in Series A Venture Financing 66
Atopix Therapeutics Raises Funds through Extended Series A Financing 67
Atox Bio Raises up to USD23 Million in Series E Venture Financing 68
Navitor Pharma Raises USD24 Million in Series A Financing 69
True North Therapeutics Raises USD22 Million in Series A Venture Financing 71
Principia Biopharma Raises US$50 Million In Series B Venture Financing 73
Spero Therapeutics Raises USD3 Million in Series A Venture Financing 75
Alios BioPharma Raises US$41 Million In Series B Venture Financing 76
RuiYi Raises US$15 Million In Series B Financing 77
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 79
VHsquared Secures Series A Funding Round 80
Aileron Therapeutics Raises US$30 Million In Series E Financing 81
Mission Therapeutics Raises US$32 Million In Series B Financing 83
F-Star Alpha Raises US$13 Million In Series A Financing 84
iPierian Raises US$30 Million In Series A Venture Financing 85
Effector Therapeutics Raises US$45 Million In Series A Financing 87
Progenitor Labs Raises US$5.8 Million In Seed Financing 89
Aileron Raises US$12 Million In Extended Series D Financing 90
River Vision Development Raises US$17 Million In Series A Financing 92
Bicycle Therapeutics Raises US$6 Million In Venture Financing 93
Applied Genetic Technologies Raises US$37.5 Million In Series B Financing 95
HTG Molecular Diagnostics Raises US$7.5 Million In Series E Financing 97
Thrasos Therapeutics Raises US$35 Million In Venture Financing 98
SR One Plans To Invest In Biotechnology Company 100
Genocea Biosciences Raises US$30 Million In Series C Financing 101
Principia Biopharma Raises Additional US$13 Million In Series A Financing 103
PsiOxus Therapeutics Raises Additional US$34 Million In Series B Financing 105
RaNA Therapeutics Raises Additional US$18 Million In Series A Financing 107
Mission Therapeutics Raises US$10 Million In Series A Financing 109
Nimbus Discovery Secures US$24 Million In Series A Financing 110
High Throughput Genomics Secures US$0.5 Million In Second Closing Of Series D Venture Round 111
Constellation Pharma Secures Additional US$15 Million In Series B Financing 112
f-star Secures US$21.7 Million In Financing Round 114
Principia Biopharma Raises US$12 Million In First Tranche Of Series A Financing 116
Genocea Biosciences Secures US$35 Million In Series B Venture Financing 117
Ipsen Acquires Syntaxin, Life Sciences Company, For US$206 Million 119
SuperGen Completes Acquisition Of Astex Therapeutics 121
SR One Ltd, Key Competitors 124
SR One Ltd, Key Employees 125
SR One Ltd, Other Locations 126